Fusion Antibodies (FAB)

Sector:

Health Care

Index:

FTSE AIM All-Share

 11.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 19.25
  • 52 Week Low: 9.13
  • Currency: UK Pounds
  • Shares Issued: 125.16m
  • Volume: 122,478
  • Market Cap: £14.08m
  • RiskGrade: 464

FAB Overview

Fusion Antibodies is a Collaborative Research Organisation (CRO) with its headquarters in Northern Ireland. We are world leaders in antibody development services specializing in the discovery, engineering and supply of pre-clinical biologics through to clinical Cell Line Development.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -53.7% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 6.9 n/a
Pr/Book 8.9  
Latest F'cast
Revenue 7.4% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

FAB Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-22 4.80 (1.33) (4.60)p n/a n/a n/a n/a 0.0%
31-Mar-23 2.90 (2.86) (10.00)p n/a n/a n/a n/a 0.0%
31-Mar-24 1.14 (2.29) (3.90)p n/a n/a n/a n/a 0.0%
31-Mar-25 1.97 (1.63) (1.70)p n/a n/a n/a n/a 0.0%
31-Mar-26 2.11 (1.15) (1.20)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Latest FAB Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

FAB Market Data

Currency UK Pounds
Share Price 11.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 19.25
52 Week Low 9.13
Volume 122,478
Shares Issued 125.16m
Market Cap £14.08m
RiskGrade 464

FAB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.33% below the market average32.33% below the market average32.33% below the market average32.33% below the market average32.33% below the market average
61.54% below the sector average61.54% below the sector average61.54% below the sector average61.54% below the sector average61.54% below the sector average
Price Trend
50.83% above the market average50.83% above the market average50.83% above the market average50.83% above the market average50.83% above the market average
79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average
Income Not Available
Growth
27.07% above the market average27.07% above the market average27.07% above the market average27.07% above the market average27.07% above the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average

FAB Dividends

No dividends found

Trades for 05-Oct-2026

Time Volume / Share Price
15:32 4,605 @ 11.01p
14:51 4,700 @ 11.24p
12:45 28 @ 11.00p
12:45 15,889 @ 11.11p
10:17 875 @ 11.33p

FAB Key Personnel

Chair Simon Gordon Douglas
CEO Adrian Kinkaid

Top of Page